Robin Y. Smith brings over 20 years of startup, science, and entrepreneurial experience to ORIG3N, where he serves as CEO. An ambitious entrepreneur with a reputation for being at the forefront of innovation, Robin consistently identifies opportunities for improvement and delivers elegant and comprehensive solutions.
In his former roles as founder of three successful enterprises, Robin returned 78% IRR to investors at two VC-backed companies. His previous venture, ArtusLabs, was acquired by PerkinElmer in 2011. As the global head of R&D for PerkinElmer, Robin managed teams as large as 500 people. Robin is a visionary and strategist who is passionate about building high-energy startup organizations that are grounded in humanity and focused on the future. His belief that access to health care should be available to all prompted him, along with Kate Blanchard, to found ORIG3N with the goal of democratizing access to treatment and science technology, and personalizing medicine.